Rheumatology Network's Top 5: June 11, 2022

Article

Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending June 11, 2022.

Line Uhrenholt, MD: Disease Activity-Guided Tapering in Patients with Inflammatory Arthritis

Line Uhrenholt, MD, discusses the results of her randomized, open-label, equivalence trial study evaluating disease activity-guided tapering of biologics in patients with inflammatory arthritis.

Karin Schenck-Gustafsson, MD, PhD, FESC: Why Sex and Gender Must be Considered in Disease Treatment

Karin Schenck-Gustafsson, MD, PhD, FESC, explains why sex and gender must be taken into account when treating and managing patients with rheumatic disease from a cardiologist's perspective.

Patients with RA Hesitant to Make Changes to DMARD Therapy

Investigators believe that treatment escalation within patients with rheumatoid arthritis should utilize interventions beyond the traditional physician-patient relationship.

Actigraphy: Complimentary Clinical Tool to Evaluate Sleep in Patients with RA

Findings suggested that actigraphy may provide additional information to self-reported sleep measures in patients with rheumatoid arthritis.

Personal History of Psoriasis Linked to Axial Joint Disease in Psoriatic Arthritis

A personal history rather than a family history of psoriasis is associated with the disease activity and severity of axial joint damage.

Related Videos
Signs and Symptoms of Connective Tissue Disease
Connective Tissue Disease Brings Dermatology & Rheumatology Together
© 2024 MJH Life Sciences

All rights reserved.